2F50:FRA
Scinai Immunotherapeutics Ltd - ADR
arrow_downward
-100.00%(-2.26) 1D
Sep 10, 11:45:58 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2F50...
Mkt. cap
951.94K
Volume
0.00
52-wk high
€136.00
52-wk low
€18.20
No. of employees
45
Mkt. cap
951.94K
Volume
0.00
52-wk high
€136.00
52-wk low
€18.20
No. of employees
45
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR